Voltage-gated calcium channel (presynaptic subtype) (VGCC (general); CaV (more accurate for this channel family))

Presynaptic voltage-gated calcium channels are specialized transmembrane proteins at the nerve terminal active zone that open in response to membrane depolarization, allowing the influx of Ca²⁺ ions crucial for triggering the exocytosis of synaptic vesicles and rapid neurotransmitter release. These channels exhibit subtype diversity (CaV2.1, CaV2.2, CaV2.3, CaV1.x, CaV3.x) as well as variable nanoscopic organization relative to vesicle release sites, contributing to the regulation of synaptic transmission and short-term plasticity. Pharmacological targeting of presynaptic VGCCs has proven effective for diseases such as epilepsy, chronic pain, and migraine, but drugs targeting them present potential neurological and cardiovascular risk. Auxiliary subunits and scaffold proteins further modulate their trafficking, localization, and function, making them a complex and dynamic molecular target in neurobiology

Other names

Voltage-gated calcium channelVoltage-dependent calcium channelCaV channelVDCCPresynaptic calcium channelPresynaptic CaV channel

Channel blockade (direct inhibition, as with ziconotide or ω-conotoxins) - Modulation via auxiliary subunit binding (gabapentin, pregabalin binding to α2δ subunit, affecting trafficking and function) - Down-regulation of synaptic transmission and pain signaling by reducing presynaptic calcium influx